首页 | 本学科首页   官方微博 | 高级检索  
     

保留肾单位手术治疗儿童肾细胞癌
引用本文:刘超,宋宏程,张潍平,孙宁,黄澄如. 保留肾单位手术治疗儿童肾细胞癌[J]. 中华小儿外科杂志, 2017, 0(10): 740-743. DOI: 10.3760/cma.j.issn.0253-3006.2017.10.004
作者姓名:刘超  宋宏程  张潍平  孙宁  黄澄如
作者单位:100045,首都医科大学附属北京儿童医院泌尿外科
基金项目:北京市医院管理局“登峰”人才培养计划(DFL20151102),北京市医院管理局“扬帆计划”:小儿泌尿外科(ZYLX201709),北京市卫生系统高层次卫生技术人才培养计划(2015-3-078)Beijing Hospital Authority Summit Talent Training Plan(DFL 20151102),Beijing Hospital Authority Summit Plan:Pediatric Urology(ZYLX201709),Beijing Health System Top level Health Technical Personnel Training Plan(2015-3-078)
摘    要:目的 探讨保留肾单位手术治疗儿童肾细胞癌的安全性和可行性.方法 对我院1973年1月至2016年12月收治的11例行保留肾单位手术治疗儿童肾细胞癌的临床资料进行回顾性分析.男8例,女3例;年龄4.5~13.5岁,平均7.5岁;左侧5例,右侧6例.临床表现:无痛肉眼血尿4例,腹部包块1例,行B型超声检查偶然发现6例,血尿病史1~7个月,平均3个月.结果 11例患儿均行开放性经腹膜保留肾单位手术,肿瘤直径2.2~6.9 cm,平均3.3 cm.肿瘤位于肾上极4例,肾中极背侧1例、肾中极腹侧1例、肾下极5例.手术时间88~175min,平均107 min,术中阻断肾蒂时间19~25min,平均20.4 min,出血量10~100ml,平均35ml.本组手术均安全进行,无继发出血、漏尿等并发症.术后病理提示9例为Xp 11.2易位/TFE3基因融合相关性肾癌,1例为透明细胞癌,1例为嫌色细胞癌.11例均获随访,随访时间25~129个月,平均53.2个月,无复发及死亡病例.结论 儿童肾癌应用保留肾单位手术的指征应十分严格,在此前提下,保留肾单位手术治疗儿童肾癌安全、可行.

关 键 词:肾细胞癌  保留肾单位手术  随访

Safety and feasibility of nephron-sparing surgery for pediatric renal cell carcinoma
Liu Chao,Song Hongcheng,Zhang Weiping,Sun Ning,Huang Chengru. Safety and feasibility of nephron-sparing surgery for pediatric renal cell carcinoma[J]. Chinese Journal of Pediatric Surgery, 2017, 0(10): 740-743. DOI: 10.3760/cma.j.issn.0253-3006.2017.10.004
Authors:Liu Chao  Song Hongcheng  Zhang Weiping  Sun Ning  Huang Chengru
Abstract:Objective To explore the safety and feasibility of nephron-sparing surgery (NSS) for pediatric renal cell carcinoma (RCC).Methods The clinical characteristics of 11 RCC children (8 males and 3 females) undergoing NSS between January 1973 and December 2016 were retrospectively analyzed.The mean age was 7.5 (4.5-13.5) years.RCC was involved at left (n=5) and right (n=6).Clinical presentations included painless gross hematuria (n =4),abdominal mass (n =1) and incidental ultrasonic finding (n =6).The mean course of hematuria was 3 (1-7) months.Results All NSS procedures were completed via an open transperitoneal approach.The mean tumor diameter was 3.7 (2.2-6.9) cm.The locations of renal tumors were in upper pole (n =4),mid-dorsal (n =1),midventral (n =1) and lower pole (n =5).The mean operative duration was 107 (88-175) min and estimated volume of blood loss 35 (10-100) ml.And the mean duration of renal pedicle clamping was 20.4 (19-25) min.No such complications as leakage of urine,prolonged drainage or secondary bleeding were noted.The pathological types were RCC associated with Xp1 1.2 translocation/TFE3 gene fusions (n=9),clear cell carcinoma (n =1) and chromophobe carcinoma (n =1).There was no local recurrence during a mean follow-up period of 53.2 (25-129) months.Conclusions The surgical indications of NSS should be strictly grasped for pediatric RCC.And NSS is both safe and feasible for renal cell carcinomas.
Keywords:Renal cell carcinoma  Nephron-sparing surgery  Follow-up
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号